Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Boyett

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Journal of Biopharmaceutical Statistics|April 23, 2009
Continual reassessment method vs. traditional empirically based design: modifications motivated by Phase I trials in pediatric oncology by the Pediatric Brain Tumor ConsortiumArzu Onar, Mehmet Kocak, James M Boyett
Clinical and Translational Science|May 7, 2010
An operational perspective of challenging statistical dogma while establishing a modern, secure distributed data management and imaging transport system: the Pediatric Brain Tumor Consortium phase I experienceArzu Onar, Uma Ramamurthy, Dana Wallace, et al.
Health Care Financing Review|December 26, 2002
Disenrollment and re-enrollment patterns in a SCHIPElizabeth A Shenkman, Bruce Vogel, James M Boyett, et al.
Journal of Mathematical Biology|October 11, 2008
A stochastic model for estimation of mutation rates in multiple-replication proliferation processesXiaoping Xiong, James M Boyett, Robert G Webster, et al.
Theoretical Biology & Medical Modelling|March 29, 2011
Maximum likelihood estimation of reviewers' acumen in central review setting: categorical dataWei Zhao, James M Boyett, Mehmet Kocak, et al.
Statistics in Medicine|November 30, 2006
Pseudoscore-based estimation from biased observationsX Joan Hu, R Jason Schroeder, Winfred C Wang, et al.
Journal of Neuro-Oncology|June 20, 2003
Combined modality therapy for poorly differentiated gliomas of the posterior fossa in children: a Children's Cancer Group reportSalvatore J Bertolone, Allan J Yates, James M Boyett, et al.
BMC Bioinformatics|July 22, 2009
A statistical framework to evaluate virtual screeningWei Zhao, Kirk E Hevener, Stephen W White, et al.
Statistical Applications in Genetics and Molecular Biology|May 2, 2006
Statistical significance threshold criteria for analysis of microarray gene expression dataCheng Cheng, Stanley B Pounds, James M Boyett, et al.
Pediatric Blood & Cancer|August 20, 2013
Cumulative cisplatin dose is not associated with event-free or overall survival in children with newly diagnosed average-risk medulloblastoma treated with cisplatin based adjuvant chemotherapy: report from the Children's Oncology GroupAmulya A Nageswara Rao, Dana J Wallace, Catherine Billups, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Journal of Biopharmaceutical Statistics|April 23, 2009
Continual reassessment method vs. traditional empirically based design: modifications motivated by Phase I trials in pediatric oncology by the Pediatric Brain Tumor ConsortiumArzu Onar, Mehmet Kocak, James M Boyett
Clinical and Translational Science|May 7, 2010
An operational perspective of challenging statistical dogma while establishing a modern, secure distributed data management and imaging transport system: the Pediatric Brain Tumor Consortium phase I experienceArzu Onar, Uma Ramamurthy, Dana Wallace, et al.
Health Care Financing Review|December 26, 2002
Disenrollment and re-enrollment patterns in a SCHIPElizabeth A Shenkman, Bruce Vogel, James M Boyett, et al.
Journal of Mathematical Biology|October 11, 2008
A stochastic model for estimation of mutation rates in multiple-replication proliferation processesXiaoping Xiong, James M Boyett, Robert G Webster, et al.
Theoretical Biology & Medical Modelling|March 29, 2011
Maximum likelihood estimation of reviewers' acumen in central review setting: categorical dataWei Zhao, James M Boyett, Mehmet Kocak, et al.
Statistics in Medicine|November 30, 2006
Pseudoscore-based estimation from biased observationsX Joan Hu, R Jason Schroeder, Winfred C Wang, et al.
Journal of Neuro-Oncology|June 20, 2003
Combined modality therapy for poorly differentiated gliomas of the posterior fossa in children: a Children's Cancer Group reportSalvatore J Bertolone, Allan J Yates, James M Boyett, et al.
BMC Bioinformatics|July 22, 2009
A statistical framework to evaluate virtual screeningWei Zhao, Kirk E Hevener, Stephen W White, et al.
Statistical Applications in Genetics and Molecular Biology|May 2, 2006
Statistical significance threshold criteria for analysis of microarray gene expression dataCheng Cheng, Stanley B Pounds, James M Boyett, et al.
Pediatric Blood & Cancer|August 20, 2013
Cumulative cisplatin dose is not associated with event-free or overall survival in children with newly diagnosed average-risk medulloblastoma treated with cisplatin based adjuvant chemotherapy: report from the Children's Oncology GroupAmulya A Nageswara Rao, Dana J Wallace, Catherine Billups, et al.
Pageof 9